BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2157186)

  • 1. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
    Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
    Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
    Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
    Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria.
    Wang JY; Baltimore D
    J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system.
    Sun G; Budde RJ
    Arch Biochem Biophys; 1997 Sep; 345(1):135-42. PubMed ID: 9281320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
    Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
    J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli.
    Ferguson B; Pritchard ML; Feild J; Rieman D; Greig RG; Poste G; Rosenberg M
    J Biol Chem; 1985 Mar; 260(6):3652-7. PubMed ID: 2982873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
    Hines DL
    Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
    Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
    Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar.
    Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H
    Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
    Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
    Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate-determining steps for tyrosine phosphorylation by the kinase domain of v-fps.
    Wang C; Lee TR; Lawrence DS; Adams JA
    Biochemistry; 1996 Feb; 35(5):1533-9. PubMed ID: 8634284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.